Takeda Pharmaceutical Li... (TKPHF)
OTC: TKPHF
· Real-Time Price · USD
29.45
0.00 (0.00%)
At close: Aug 13, 2025, 11:10 AM
29.45
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT
Takeda Pharmaceutical Income Statement
Financials in JPY. Fiscal
year is
April - March.
| Fiscal Year | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 4,480.2B | 4,581.6B | 4,579B | 4,546.1B | 4,413.1B | 4,263.8B | 4,169B | 4,154.4B | 4,113.6B | 4,027.5B | 3,944.6B | 3,749.4B | 3,591.9B | 3,569B | 3,466B | 3,401.4B | 3,345.6B | 3,197.8B | 3,199.2B | 3,221.8B | 3,243.9B |
Cost of Revenue | 1,577.9B | 1,743B | 1,743.5B | 1,706.1B | 1,655.3B | 1,426.7B | 1,353.9B | 1,310.4B | 1,272.3B | 1,244.1B | 1,242.7B | 1,188.1B | 1,158.5B | 1,106.8B | 1,051.9B | 1,023.6B | 997.49B | 994.31B | 989.04B | 1,015.5B | 1,037.5B |
Gross Profit | 2,902.3B | 2,838.5B | 2,835.6B | 2,840B | 2,757.8B | 2,837.1B | 2,815.1B | 2,844B | 2,841.3B | 2,783.4B | 2,701.9B | 2,561.2B | 2,433.4B | 2,462.2B | 2,414.1B | 2,377.8B | 2,348.1B | 2,203.5B | 2,210.2B | 2,206.3B | 2,206.4B |
Operating Income | 360.82B | 342.59B | 604.8B | 642.77B | 409.18B | 411.42B | 312.71B | 354.78B | 508.56B | 490.5B | 400.32B | 369.82B | 362.81B | 460.84B | 613B | 639.66B | 590.54B | 509.27B | 296.59B | 206.96B | 199.1B |
Interest Income | 62.72B | 19.64B | 33.8B | 62.57B | 67.82B | 63.59B | 65.39B | 85.28B | 90.7B | 125.17B | 117.39B | 79.85B | 71.93B | 56.86B | 104.35B | 128.61B | 131.76B | 105.52B | 58.03B | 63.83B | 62.51B |
Pretax Income | 189.11B | 175.08B | 231.12B | 265.97B | 50.62B | 49.05B | 148.23B | 194.12B | 354.65B | 375.09B | 273.13B | 238.17B | 235.07B | 302.57B | 487.5B | 525.1B | 458.92B | 366.24B | 118.59B | 33.64B | 36B |
Net Income | 136.92B | 107.93B | 208.06B | 290B | 149.92B | 144.07B | 178.22B | 191.63B | 301.4B | 317.02B | 274.52B | 213.17B | 197.39B | 230.06B | 438.52B | 473.11B | 431.18B | 376B | 180.63B | 56.05B | 105.86B |
Selling & General & Admin | 1,090.6B | 1,104.8B | 1,094.1B | 1,091.1B | 1,075.7B | 1,053.8B | 1,023.4B | 1,018.2B | 1,013.9B | 997.31B | 965.94B | 934.72B | 898B | 886.36B | 897.32B | 888.89B | 893.13B | 875.66B | 894.33B | 920.9B | 927.9B |
Research & Development | 705.65B | 730.23B | 710.08B | 727.26B | 735.65B | 729.92B | 695.01B | 682.26B | 652.46B | 633.33B | 616.01B | 569.76B | 547.21B | 526.09B | 495.75B | 484.94B | 471.49B | 455.83B | 481.85B | 487B | 482.34B |
Other Expenses | 745.21B | 823.75B | 589.38B | 368.64B | 215B | -1.21B | -1.21B | -1.01B | -1.01B | -1.01B | -1.01B | n/a | -1.52B | -1.52B | -1.52B | -1.52B | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 2,541.5B | 2,658.7B | 2,393.6B | 2,398.6B | 2,549.9B | 2,464.2B | 2,540.9B | 2,489.2B | 2,332.8B | 2,292.9B | 2,301.6B | 2,191.4B | 2,070.6B | 2,001.3B | 1,801.1B | 1,738.1B | 1,757.5B | 1,694.2B | 1,913.6B | 1,999.4B | 2,007.3B |
Interest Expense | 184.78B | 137.31B | 206.93B | 241.9B | 219.97B | 219.85B | 215.6B | 228.78B | 236.06B | 231.95B | 189.02B | 155.98B | 141.85B | 157.45B | 232.69B | 248.66B | 272.85B | 248.63B | 234.31B | 215.38B | 204.71B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4,119.4B | 4,239B | 3,974.2B | 3,941.8B | 4,042.5B | 3,890.8B | 3,894.8B | 3,799.6B | 3,605.1B | 3,537B | 3,544.3B | 3,379.5B | 3,229.1B | 3,108.2B | 2,853B | 2,761.8B | 2,755B | 2,688.5B | 2,902.6B | 3,014.8B | 3,044.8B |
Income Tax Expense | 51.99B | 66.94B | 26.61B | -20.45B | -95.73B | -91.41B | -30.1B | 2.4B | 53.23B | 58.05B | -1.4B | 24.97B | 37.6B | 72.41B | 48.81B | 51.8B | 27.54B | -9.94B | -61.99B | -22.4B | -69.89B |
Shares Outstanding (Basic) | 1.56B | 1.58B | 1.58B | 1.58B | 1.59B | 1.57B | 1.57B | 1.57B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.55B | 1.57B | 1.57B | 1.55B | 1.57B | 1.56B | 1.56B | 1.56B |
Shares Outstanding (Diluted) | 1.59B | 1.58B | 1.61B | 1.61B | 1.59B | 1.57B | 1.59B | 1.57B | 1.57B | 1.61B | 1.57B | 1.56B | 1.55B | 1.55B | 1.57B | 1.58B | 1.55B | 1.57B | 1.58B | 1.57B | 1.57B |
EPS (Basic) | 87.32 | 67.86 | 131.19 | 183.54 | 94.72 | 92.29 | 114.24 | 123.49 | 193.94 | 204.35 | 177.01 | 137.29 | 126.76 | 147.92 | 280.42 | 302.59 | 275.93 | 239.78 | 115.69 | 35.93 | 67.91 |
EPS (Diluted) | 84.93 | 66.64 | 129.97 | 181.89 | 94.04 | 91.22 | 112.43 | 121.59 | 191.75 | 202.19 | 175.59 | 136.41 | 126.01 | 147.03 | 279.52 | 301.45 | 274.94 | 239.04 | 114.96 | 35.67 | 67.57 |
EBITDA | 1,138B | 1,083.1B | 1,095.9B | 1,142.9B | 895.97B | 859.32B | 1,025.5B | 1,057.4B | 1,196.3B | 1,171.4B | 1,040.5B | 980.36B | 946.17B | 1,014.7B | 1,020.4B | 1,039.5B | 988.68B | 890.19B | 817.22B | 732.66B | 833.96B |
EBIT | 373.89B | 312.39B | 341.47B | 411.3B | 185.51B | 183.83B | 322.6B | 381.68B | 537.99B | 554.32B | 441.04B | 373.04B | 355.81B | 438.91B | 568.19B | 621.75B | 579.77B | 462.87B | 317.04B | 213.15B | 228.26B |
Depreciation & Amortization | 764.12B | 774.7B | 758.37B | 758.48B | 748.72B | 728B | 702.67B | 692.49B | 677.62B | 664.4B | 655.26B | 625.67B | 598.49B | 583.15B | 503.75B | 496.22B | 494.51B | 493.15B | 496.45B | 501.53B | 505.27B |